Botanix Pharmaceuticals Ltd
ASX:BOT

Watchlist Manager
Botanix Pharmaceuticals Ltd Logo
Botanix Pharmaceuticals Ltd
ASX:BOT
Watchlist
Price: 0.29 AUD 3.57% Market Closed
Updated: Jun 1, 2024

Wall Street
Price Targets

BOT Price Targets Summary
Botanix Pharmaceuticals Ltd

Wall Street analysts forecast BOT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BOT is 0.56 AUD with a low forecast of 0.56 AUD and a high forecast of 0.58 AUD.

Lowest
Price Target
0.56 AUD
92% Upside
Average
Price Target
0.56 AUD
93% Upside
Highest
Price Target
0.58 AUD
99% Upside
Botanix Pharmaceuticals Ltd Competitors:
Price Targets
600479
ZhuZhou QianJin Pharmaceutical Co Ltd
32% Upside
AGY
Allergy Therapeutics PLC
298% Upside
300723
Yipinhong Pharmaceutical Co Ltd
48% Upside
300765
CSPC Innovation Pharmaceutical Co Ltd
33% Upside
SNDL
Sundial Growers Inc
67% Upside
PHO
Photocure ASA
54% Upside
WOCKPHARMA
Wockhardt Ltd
15% Downside
002390
Guizhou Xinbang Pharmaceutical Co Ltd
101% Upside

Revenue
Forecast

Revenue Estimate
Botanix Pharmaceuticals Ltd

For the last 8 years the compound annual growth rate for Botanix Pharmaceuticals Ltd's revenue is 19%. The projected CAGR for the next 3 years is 711%.

19%
Past Growth
711%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Botanix Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Botanix Pharmaceuticals Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BOT's stock price target?
Price Target
0.56 AUD

According to Wall Street analysts, the average 1-year price target for BOT is 0.56 AUD with a low forecast of 0.56 AUD and a high forecast of 0.58 AUD.

What is Botanix Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
711%

For the last 8 years the compound annual growth rate for Botanix Pharmaceuticals Ltd's revenue is 19%. The projected CAGR for the next 3 years is 711%.